CRESCENT BIOPHARMA, INC. (CBIO) › Net IncomeCRESCENT BIOPHARMA, INC. (CBIO) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: $3.66M2013: -$10.61M2014: -$11.12M2015: -$12.77M2016: -$31.81M2017: -$33.28M2018: -$48.27M2019: -$57.89M2020: -$51.03M2021: -$63.43M2022: -$46.69M2023: -$36.90M2024: -$37.88M2025: -$153.94M-$153.94M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$153.94M-306.4%2024-$37.88M-2.7%2023-$36.90M+21.0%2022-$46.69M+26.4%2021-$63.43M-24.3%2020-$51.03M+11.9%2019-$57.89M-19.9%2018-$48.27M-45.0%2017-$33.28M-4.6%2016-$31.81M-149.1%2015-$12.77M-14.8%2014-$11.12M-4.9%2013-$10.61M-390.1%2012$3.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share